Rheoscience A/S
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy (NCT00515632) | Rheoscience A/S | 2007-07-01 |
Track Rheoscience A/S automatically
Every clearance here is in the API, with alerts when new ones post.